News

A potential treatment for attention-deficit/hyperactivity disorder goes back to the drawing board.

The psychiatric prescribing clinician may be called upon to treat pain comorbid with bipolar disorder.

The COVID-19 pandemic has affected the mental health of residents in 2 fundamental ways; directly through infection, and indirectly, but more insidiously, through social isolation and other psychological stresses.

Bipolar disorder frequently co-occurs with OCD and complicates treatment of OCD symptoms. Special considerations are discussed.

Antipsychotic medications for young children are not being prescribed appropriately, according to a recent study.

Have you chatted recently with your patients about their social media use? This study shows how and why it is important.

Exercise can be a useful tool in managing symptoms of anxiety and depression. Learn how you can integrate exercise prescriptions into your treatment plans.

This CME will inform clinicians with unique and much-needed skill sets in diagnosing substance use disorders and managing co-occurring chronic pain.

A controversial report from the British Psychological Society draws a pair of sharp rejoinders.

What better time to set aside our differences than during the holidays?

A study in Spain uncovers the hard truth about gender inequality in mental health care.

How does a child’s physical living space impact their neurodevelopment? Can it cause them increased stress?

A diagnosis of depression, anxiety disorders, or bulimia may also indicate a heightened risk of excessive drinking.

Editor in chief emeritus of Psychiatric Times, James L. Knoll IV, MD, was recently recognized for notable achievements in the education and teaching of forensic psychiatry.

Data from a randomized phase III trial shows promise for new treatment strategy.

There are no human clinical trials or even case reports to assess or describe the efficacy of this very complex botanical. Here’s what we know.

There are 4 crucial failings in our current health care system, where the importance of relationships is ignored.

Patients want to pass on many things to their children; trauma is not one of them.

Although this year has thrown us off, there is much to be thankful for.

Researchers investigated in-hospital mortality and ICU admission in patients with COVID-19 with and without comorbid schizophrenia in a population-based cohort study.

In addition to choosing a president and other political leaders, Americans cast their votes on a host of issues relevant to psychiatrists.

Does race affect the risk of stroke in patients with depression? A new study finds some answers and some new questions.

COVID-19 may lead to changes in personality and behavior, which require treatment across the continuum of care.

A new, unique long-acting injectable for treating schizophrenia may be on the way.

While incarceration is the definitive “treatment” for some, psychopathy exists on a spectrum like any other mental disorder; more recent research suggests the condition is capable of responding to treatment.

Writing for big media outlets like CNN is not always easy, but it is a great opportunity to educate the public.

Defense attorneys have concerns regarding their client’s competency in about 8% to 15% of felony prosecutions. That is where psychiatrists come in.

A recent study found riluzole may effectively combat hyperarousal symptoms in combat veterans with PTSD.

David Osser, MD, comments on the low priority of valproate for treating patients with bipolar disorder.

Is valproic acid dismissed out of hand? Three doctors discuss its potential as a treatment.